No Data
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
What Shunten International (Holdings) Limited's (HKG:932) 26% Share Price Gain Is Not Telling You
SHUNTEN INTL: 2024/2025 INTERIM REPORT
SHUNTEN INTL: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Shunten International Expects to Swing to Loss in H1
shunten intl (00932) issued a profit warning, expecting a mid-term comprehensive loss attributable to shareholders of around 2 million to 6 million Hong Kong dollars.
shunten intl (00932) announced that the group expects to achieve... until the six months ending on September 30, 2024.
The Market Doesn't Like What It Sees From Shunten International (Holdings) Limited's (HKG:932) Earnings Yet As Shares Tumble 30%
